Facility
Huahai Cangnan API Plant
Primary API manufacturing site; received FDA warning letter in 2018 after NDMA contamination in valsartan API; also supplies psychiatric APIs
1
Inputs produced
1
Goods downstream
0
Incidents on record
0
Stories
What's produced here
1 input from this facility
Tap an input to see every good that depends on it, every country that produces it, and every other company in the supply chain.
Where it shows up